Eva M Peñas-Lledó (Eva Peñas-Lledó)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Rheumatoid Arthritis

Oxide Nanoparticles

Interstitial Lung Disease

Clinical Decision Support

Top Venues

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics 25 (2) (2024)
Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics 25 (2) (2024)
Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics (2024)
Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics 25 (2) (2024)
Martha Sosa-Macias, Ingrid Fricke-Galindo, Humberto Fariñas, Lucero Monterde, Eugenia Dolores Ruiz-Cruz, Juan Arcadio Molina-Guarneros, Eduardo Martín Tarazona Santos, Fernanda Rodrigues-Soares, Carlos Galaviz-Hernández, Eva M Peñas-Lledó, Graciela Moya, Julio Lara-Riegos, Enrique Terán, Isabel Hernández, Ronald Ramírez-Roa, Catalina Altamirano-Tinoco, Marisol López-López, José Elías García-Ortiz, Adrián LLerena
Pharmacogenetics: ethnicity, treatment and health in Latin American populations. Pharmacogenomics (2023)
Ingrid Fricke-Galindo, Helgi Jung-Cook, Iris E Martínez-Juárez, Nancy Monroy-Jaramillo, Alberto Ortega-Vázquez, Irma S Rojas-Tomé, Pedro Dorado, Eva M Peñas-Lledó, Adrián LLerena, Marisol López-López
Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital. Pharmacogenomics 22 (15) (2021)